US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

697.72

-44.2669-5.97%

Number of Gainers:- -

Number of Losers:4

Number of Flat:- -

PE:- -

High:741.64

Open:737.24

Low:693.99

Close:741.99

Volume:22.06M

Turnover:735.43M

Market Cap:21.95B

Float Cap:17.17B

Loading ...

Tempus AI (TEM) Could Be 18% Below Fair Value As FDA Clearance Lands

Simply Wall St.

CRISPR Therapeutics (CRSP) Stock May Look Rich Following Fresh CTX310 Data

Simply Wall St.

Crispr Therapeutics AG (CRSP) Gets a Buy from William Blair

Tempus AI CEO, Chairman Eric Lefkofsky Reports Disposal of Common Shares Worth $12.43 Million

Tempus AI Diagnostics CEO Thomas Edward Schoenherr Reports $188,580 Tempus AI Common Share Sale

Option Focus | Tempus AI's $1.06 Million Call Sale at $100 Strike Caps Upside While Protective Put Buying Signals Bearish Institutional Sentiment

tempus AI Inc Class A call volume above normal and directionally bullish

Tempus AI Inc Stock (TEM) Moved Down by 7.10% on Aug 24: Key Drivers Unveiled

Tempus AI receives FDA clearance for Tempus ECG-PH

Tempus AI Wins FDA Clearance for ECG Software Flagging Pulmonary Hypertension Signs

Tempus Receives FDA Clearance for Its AI Product Intended to Detect Signs of Pulmonary Hypertension from Standard Ecgs

THOMSON REUTERS

Tempus AI Inc Stock (TEM) Moved Up by 8.36% on Aug 21: Drivers Behind the Movement

Tempus AI CFO James William Rogers Disposes of USD 2.7 Million in Common Shares

Tempus AI Inc Stock (TEM) Moved Up by 10.87% on Aug 20: What Signal Does It Send?

Tempus AI up over 22%, on Pace for Largest Percent Increase Since January 2025

Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why

Tempus AI rises 20.1%

tempus AI Inc Class A call volume above normal and directionally bullish

Tempus AI Director Nadja West Disposes of 3,000 Common Shares Worth $161,700

Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BK4611/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":697.71814,"timestamp":1787947199999,"preClose":741.98505,"halted":0,"volume":22058524,"delay":0,"changeRate":-0.05966,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-44.266907,"latestTime":"08-28 16:00:00 EDT","open":737.2405,"high":741.6425,"low":693.98706,"amount":735429011.754582,"amplitude":0.064227,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.602893,"peRate":-17.838791,"turnoverRate":0.026832,"increases":0,"decrements":4,"flats":0,"marketCap":21951432448,"floatMarketCap":17172530688},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":741.6425,"amplitude":0.064227,"preClose":741.98505,"low":693.98706,"pbRate":"5.602893","latestPrice":697.71814,"volume":22058524,"delay":0,"open":737.2405,"prevYearClose":658.3995,"prevWeekClose":750.3989,"prevMonthClose":543.3925,"prevQuarterClose":681.0329,"fiveDayClose":750.3989,"twentyDayClose":543.3925,"sixtyDayClose":601.6085,"secType":"PLATE","market":"US","turnoverRate":0.026832,"peRate":-17.838791,"marketCap":21951432448,"floatMarketCap":17172530688,"timestamp":1787947199999,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":0,"down":4,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663044562","title":"Tempus AI (TEM) Could Be 18% Below Fair Value As FDA Clearance Lands","url":"https://stock-news.laohu8.com/highlight/detail?id=2663044562","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663044562?lang=en_us&edition=fundamental","pubTime":"2026-08-30 19:20","pubTimestamp":1788088855,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) shares are drawing attention after the company received 510(k) clearance from the U.S. Food and Drug Administration for Tempus ECG-PH, its AI software for detecting pulmonary hypertension from standard ECGs.\nThe FDA news lands after a volatile stretch for Tempus AI, with the share price down 9.41% over the past day and 11.90% over the past week, yet still posting a 45.98% 30 day share price return and a 21.29% 90 day share price return. The 1 year total shareholder return is...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-could-be-18-below-fair-value-as-fda-clearance","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tem/tempus-ai/news/tempus-ai-tem-could-be-18-below-fair-value-as-fda-clearance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1861559042.SGD","BK4613","TEMC","TEMT","TEM","HEAL","BK4121","ARKG","BK4611","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663457750","title":"CRISPR Therapeutics (CRSP) Stock May Look Rich Following Fresh CTX310 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2663457750","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663457750?lang=en_us&edition=fundamental","pubTime":"2026-08-30 11:25","pubTimestamp":1788060309,"startTime":"0","endTime":"0","summary":"CRISPR Therapeutics stock has had a strong shorter term recovery, yet longer term holders are still sitting on a large loss, and current valuation checks lean more toward an expensive reading than a clear bargain.\n\nThe share price is down about 52.7% over 5 years, which means many longer term investors are still under water even after more recent gains.\nFresh Phase 1a data for CTX310 presented at the ESC Congress 2026 may support confidence in CRISPR Therapeutics drug pipeline, while clinical...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-stock-may-look-rich-following-fresh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-crsp/crispr-therapeutics/news/crispr-therapeutics-crsp-stock-may-look-rich-following-fresh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4588","BK4556","BK4611","LU1861558580.USD","LU1861559042.SGD","BK4585","ARKG","SYNB","CRSP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663014328","title":"Crispr Therapeutics AG (CRSP) Gets a Buy from William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2663014328","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663014328?lang=en_us&edition=fundamental","pubTime":"2026-08-29 13:17","pubTimestamp":1787980638,"startTime":"0","endTime":"0","summary":"William Blair analyst Sami Corwin maintained a Buy rating on Crispr Therapeutics AG yesterday. The company’s shares closed yesterday at $57.72. Acc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/crispr-therapeutics-ag-crsp-gets-a-buy-from-william-blair-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/crispr-therapeutics-ag-crsp-gets-a-buy-from-william-blair-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","BK4585","CRSP","ARKG","LU1861558580.USD","BK4588","LU1861559042.SGD","BK4556","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662034721","title":"Tempus AI CEO, Chairman Eric Lefkofsky Reports Disposal of Common Shares Worth $12.43 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662034721","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662034721?lang=en_us&edition=fundamental","pubTime":"2026-08-28 08:28","pubTimestamp":1787876882,"startTime":"0","endTime":"0","summary":"Tempus AI CEO, Chairman Eric Lefkofsky reports disposal of common shares worth $12.43 millionTempus AI CEO and Chairman Eric P. Lefkofsky disclosed sales of 220,692 Class A common shares on Aug. 25, 2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nNDL1bD3X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI CEO, Chairman Eric Lefkofsky Reports Disposal of Common Shares Worth $12.43 Million","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","BK4611","TEMC","ARKG","LU1861559042.SGD","LU1861558580.USD","BK4121","BK4613","TEMT","TEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662791881","title":"Tempus AI Diagnostics CEO Thomas Edward Schoenherr Reports $188,580 Tempus AI Common Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2662791881","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662791881?lang=en_us&edition=fundamental","pubTime":"2026-08-26 17:08","pubTimestamp":1787735338,"startTime":"0","endTime":"0","summary":"Tempus AI Diagnostics CEO Thomas Edward Schoenherr reports $188,580 Tempus AI common share saleTempus AI Diagnostics CEO Thomas Edward Schoenherr bought 2,694 shares of Class A common stock on Aug. 21","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL4zT77v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAL","BK4613","LU1861559042.SGD","LU1861558580.USD","TEM","TEMC","BK4121","ARKG","TEMT","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177992159","title":"Option Focus | Tempus AI's $1.06 Million Call Sale at $100 Strike Caps Upside While Protective Put Buying Signals Bearish Institutional Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=1177992159","media":"Option Witch","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177992159?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:02","pubTimestamp":1787698920,"startTime":"0","endTime":"0","summary":"Tempus AI closed at USD 68.73, up 3.87%.Large options trades in TEM tilted bearish. A $1.06 million call sale at the $100.00 strike stood out, while a $161 thousand put purchase at the $50.00 strike...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JULD","TEM","ARKG","BK4611","RSEE","TEMC","HEAL","LU1861559042.SGD","LU1861558580.USD","QQQP","CHAT","ARTY","BK4121","TEMT","VTHR","AGIX","BK4613","AIPO","QTOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662756186","title":"tempus AI Inc Class A call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2662756186","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662756186?lang=en_us&edition=fundamental","pubTime":"2026-08-26 00:05","pubTimestamp":1787673917,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in tempus AI (TEM) Inc Class A with 17,092 calls trading, 1.2x expected, and implied vol increasing over 4 points to 8...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-call-volume-above-normal-and-directionally-bullish-thefly-news-5?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-call-volume-above-normal-and-directionally-bullish-thefly-news-5?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861559042.SGD","TEM","BK4611","ARKG","BK4121","HEAL","TEMT","LU1861558580.USD","BK4613","TEMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662420353","title":"Tempus AI Inc Stock (TEM) Moved Down by 7.10% on Aug 24: Key Drivers Unveiled","url":"https://stock-news.laohu8.com/highlight/detail?id=2662420353","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662420353?lang=en_us&edition=fundamental","pubTime":"2026-08-25 01:15","pubTimestamp":1787591717,"startTime":"0","endTime":"0","summary":"• Tempus AI shares declined due to profit-taking despite receiving FDA clearance.\n• Technical overextension and insider share sales exacerbated the stock price retracement.\n• The company reported $1.27B annual revenue and a net loss of $-245.03M.","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262128326-market-movers-tem-20260824","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","LU1861559042.SGD","BK4613","HEAL","TEM","TEMT","BK4611","BK4121","ARKG","TEMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661672279","title":"Tempus AI receives FDA clearance for Tempus ECG-PH","url":"https://stock-news.laohu8.com/highlight/detail?id=2661672279","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661672279?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575241,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced it has received 510(k) clearance from the U.S. Food and Drug Administration, FDA, for Tempus ECG-PH, an AI-enabled softwa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-receives-fda-clearance-for-tempus-ecg-ph-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-receives-fda-clearance-for-tempus-ecg-ph-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","TEMC","HEAL","BK4121","ARKG","LU1861559042.SGD","TEM","BK4613","TEMT","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276048","title":"Tempus AI Wins FDA Clearance for ECG Software Flagging Pulmonary Hypertension Signs","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276048","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276048?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:31","pubTimestamp":1787574680,"startTime":"0","endTime":"0","summary":"Tempus AI wins FDA clearance for ECG software flagging pulmonary hypertension signsTempus AI won FDA 510(k) clearance for Tempus ECG-PH, an AI tool that flags signs of pulmonary hypertension from stan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLbZvkQD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","HEAL","TEMC","LU1861558580.USD","BK4121","BK4611","TEM","BK4613","ARKG","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661765276","title":"Tempus Receives FDA Clearance for Its AI Product Intended to Detect Signs of Pulmonary Hypertension from Standard Ecgs","url":"https://stock-news.laohu8.com/highlight/detail?id=2661765276","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661765276?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:30","pubTimestamp":1787574600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUA969CFK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HEAL","ARKG","BK4613","BK4121","LU1861558580.USD","LU1861559042.SGD","TEMT","TEM","BK4611","TEMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661292406","title":"Tempus AI Inc Stock (TEM) Moved Up by 8.36% on Aug 21: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661292406","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661292406?lang=en_us&edition=fundamental","pubTime":"2026-08-22 02:15","pubTimestamp":1787336125,"startTime":"0","endTime":"0","summary":"• Tempus AI rose due to analyst upgrades and precision oncology expansion.\n• Second-quarter results showed improved gross margins and positive net income.\n• Technical indicators show a buy signal alongside overbought conditions.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262125151-market-movers-tem-20260821","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","BK4613","TEM","LU1861558580.USD","TEMC","HEAL","BK4611","BK4121","TEMT","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661351255","title":"Tempus AI CFO James William Rogers Disposes of USD 2.7 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2661351255","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661351255?lang=en_us&edition=fundamental","pubTime":"2026-08-21 09:00","pubTimestamp":1787274055,"startTime":"0","endTime":"0","summary":"Tempus AI CFO James William Rogers disposes of USD 2.7 million in common sharesTempus AI CFO James William Rogers sold 48,842 Class A common shares on Aug. 18-19, 2026.Sale prices were USD 49.61 per s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL9MQ6Ty:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI CFO James William Rogers Disposes of USD 2.7 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TEMT","BK4121","TEM","HEAL","LU1861558580.USD","BK4613","ARKG","LU1861559042.SGD","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661235022","title":"Tempus AI Inc Stock (TEM) Moved Up by 10.87% on Aug 20: What Signal Does It Send?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661235022","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661235022?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:15","pubTimestamp":1787242518,"startTime":"0","endTime":"0","summary":"• Merck and Moderna released favorable Phase 3 trial results for individualized mRNA cancer vaccines.\n• BTIG Research reaffirmed a Buy rating and raised Tempus AI's price target.\n• Tempus AI reported strong revenue expansion, gross margins, and raised full-year guidance.","market":"fut","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262121723-market-movers-tem-20260820","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","TEM","HEAL","BK4611","TEMT","LU1861559042.SGD","BK4121","ARKG","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660271724","title":"Tempus AI up over 22%, on Pace for Largest Percent Increase Since January 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2660271724","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660271724?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:57","pubTimestamp":1787162220,"startTime":"0","endTime":"0","summary":"Tempus AI, Inc. Class A  is currently at $60.29, up $10.93 or 22.14%--Would be highest close since July 9, 2026, when it closed at $61.50--On pace for largest percent increase since Jan. 21, 2025, when it rose 35.53%--Snaps a five day losing streak--Up 37.43% month-to-date--Up 2.1% year-to-date--Down 41.61% from its all-time closing high of $103.25 on Oct. 8, 2025--Down 17.73% from 52 weeks ago , when it closed at $73.28--Down 41.61% from its 52-week closing high of $103.25 on Oct. 8, 2025--Up 45.1% from its 52-week closing low of $41.55 on July 29, 2026--Traded as high as $61.40; highest intraday level since July 10, 2026, when it hit $62.95--Up 24.39% at today's intraday high; largest intraday percent increase since Jan. 21, 2025, when it rose as much as 41.76%All data as of 1:53:34 PM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4613","LU1861558580.USD","TEM","BK4611","HEAL","ARKG","LU1861559042.SGD","BK4121","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660042204","title":"Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2660042204","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660042204?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:04","pubTimestamp":1787159095,"startTime":"0","endTime":"0","summary":"Tempus AI ($TEM) surged nearly 24% on Wednesday after a major Phase 3 cancer vaccine update from Merck ($MRK) and Moderna ($MRNA). The news instant...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/tempus-ai-stock-tem-is-surging-24-on-wednesday-heres-why?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/tempus-ai-stock-tem-is-surging-24-on-wednesday-heres-why?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","LU1861558580.USD","BK4121","LU1861559042.SGD","BK4613","HEAL","TEMT","ARKG","TEM"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2660422382","title":"Tempus AI rises 20.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660422382","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660422382?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:05","pubTimestamp":1787155531,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) is up 20.1%, or $9.94 to $59.30. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ne...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-rises-20-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-rises-20-1-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARKG","HEAL","TEMT","LU1861559042.SGD","TEM","LU1861558580.USD","BK4613","BK4611","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660424234","title":"tempus AI Inc Class A call volume above normal and directionally bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=2660424234","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660424234?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:45","pubTimestamp":1787154309,"startTime":"0","endTime":"0","summary":"Bullish option flow detected in tempus AI (TEM) Inc Class A with 47,702 calls trading, 8x expected, and implied vol increasing almost 12 points to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-call-volume-above-normal-and-directionally-bullish-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-inc-class-a-call-volume-above-normal-and-directionally-bullish-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEMT","ARKG","LU1861558580.USD","HEAL","TEM","LU1861559042.SGD","BK4611","BK4613","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660940894","title":"Tempus AI Director Nadja West Disposes of 3,000 Common Shares Worth $161,700","url":"https://stock-news.laohu8.com/highlight/detail?id=2660940894","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660940894?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:16","pubTimestamp":1787084176,"startTime":"0","endTime":"0","summary":"Tempus AI director Nadja West disposes of 3,000 common shares worth $161,700Tempus AI director Nadja West sold 3,000 shares of Class A common stock on Aug. 14, 2026 at $53.9.Post-transaction holdings ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL6wtwZX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI Director Nadja West Disposes of 3,000 Common Shares Worth $161,700","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","TEMT","BK4613","BK4611","ARKG","TEM","LU1861559042.SGD","HEAL","LU1861558580.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660435025","title":"Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2660435025","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660435025?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:01","pubTimestamp":1786978897,"startTime":"0","endTime":"0","summary":"Contineum Therapeutics , Disc Medicine , and Recursion Pharmaceuticals  are making meaningful pipeline progress, with key clinical and regulatory catalysts ahead in 2026, Morgan Stanley said in a note Monday.Contineum had a solid Q2, with the company advancing PIPE-791 toward a potentially large idiopathic pulmonary fibrosis opportunity, backed by strong trial progress, better tolerability, additional chronic-pain potential, and enough cash to fund operations through mid-2029, the investment firm said.Morgan Stanley said Disc Medicine is seeing \"very strong\" demand for bitopertin, with its expanded access program launched ahead of a phase 3 trial readout expected in Q4. Management says demand is currently limited by operational bandwidth, not patient interest, according to the note.Recursion Pharmaceuticals is showing growing validation of its artificial intelligence drug-discovery platform, the firm said. The company cut its 2026 cash spending forecast to about $375 million from rough","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","RXRX","LU0053671581.USD","BK4139","BK4611","BK4609","CTNM","BK4007","BK4548","IRON"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}